38 funding opportunities are listed in this category
International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)
Goal: To provide seed funding for early stage drug discovery and development efforts.Funding: The program provides funding in amounts ranging from $25,000-$50,000 for one year with a high likelihood of follow-on funding for successful programs.HeART Award Timeline
Cycle 1 LOIS due: March 26, 2010Applications due: April 26, 2010
Cycle 2
LOIs due: August 16, 2010Applications due: September 30, 2010
International Rett Syndrome Foundation 4600 Devitt DriveCincinnati OH 45246Telephone: 1-800-818-7388Fax: 1-513-874-2520
Multiple Sclerosis Center Quality of Life Grants
Since 1996, the Multiple Sclerosis Foundation (MSF) has awarded grants and endowments to universities, MS centers, and other nonprofit organizations to actively promote quality of life and create a brighter tomorrow for those living with MS. MS centers and nonprofit organizations, with a physical presence in the United States, in need of expanding their programs and services are also eligible for financial assistance from the MSF. Grants are available for implementing or expanding MS Day Programs, diagnostic services, rehabilitation services, support services, social services, education and outreach, and medical care.Applications are accepted beginning September 1st of each year. Applications must be postmarked between September 1st and November 1st to be eligible for funding.
Eligibility:• New and existing centers with a physical presence in the United States.• Centers serving twenty-five or more MS patients.
Priority will be given to efforts that:• Address unmet needs• Enhance or expand current services• Use creative and innovative approaches to achieve positive outcomes• Fill gaps in current services
Areas not funded:• Grants for research• Grants to individuals• Grants for religious purposes• Grants for items covered under existing MSF programs
Size and types of grants:• Funding decisions will be based on the type and scope of the program. Due to the wide variety of program designs expected, varying amounts of funding will be provided. Generally, the MSF funds programs in the range of $5,000 to $40,000.For further information on the MS Center Quality of Life grant, call Alan Segaloff, Executive Director at 1-800-225-6495.
Multiple Sclerosis Foundation6350 North Andrews AvenueFort Lauderdale, Florida 33309-2130
Multiple Sclerosis Foundation Grant Program
The initial contact should be made by letter of inquiry stating the amount sought, purpose of the grant, and nature of the organization requesting the grant. Please include an e-mail address if available. The letter should be sent to: The Grant Committee c/o Managing Director Multiple Sclerosis Foundation 6350 North Andrews Avenue Ft. Lauderdale, Fl. 33309If you are awarded a grant we do ask as a minimum that you provide us with semi-annual progress reports however additional criteria may apply depending on the amount and type of grant.FUNDING CYCLEAll grant requests, excluding the Brighter Tomorrow grant, must be postmrked between September 1 and November 1 of each year. If your request is funded, funding will occur prior to January 15 of the following year.LIMITATIONS AND EXCLUSIONSThe Multiple Sclerosis Foundation, at its sole discretion, has the right to limit, refuse or cancel any grants made. The awarding of grants is at the determination of the Multiple Sclerosis Foundation.
Multiple Sclerosis Foundation Computer Grant Program
Computer Grant Program provides refurbished laptop or desktop computers for individuals with MS on limited or fixed incomes. For those who do not know how to use a computer, training may be provided. The application process requires verification of a diagnosis of MS and a brief essay from the applicant explaining how a computer will enhance their quality of life. A computer, monitor, keyboard and mouse will be granted. Internet access and technical support will be the responsibility of the grant recipient. Applications are accepted from July 1 to October 1 of each year.
Multiple Sclerosis Foundation Brighter Tomorrow Grant
Each year the Multiple Sclerosis Foundation makes dreams come true for individuals with multiple sclerosis across the country through the Brighter Tomorrow grant.The goal of the grant is provide individuals with MS with goods or services (valued at up to $1000.00 per recipient) to improve their quality of life by enhancing safety, self-sufficiency, comfort, or well-being.Recipients of the Multiple Sclerosis Foundation's Brighter Tomorrow grant have received car repairs, ramps, wheelchairs, walkers, eyeglasses, computers, appliances, televisions, furniture, therapeutic equipment, hobby supplies, retreats, and various home modifications.To qualify, a person must be 18 years of age or older and diagnosed with MS, or the parent of a minor child diagnosed with MS, and be a permanent U.S. resident. They must not have any other means of fulfilling the need they express.Applicants are asked to provide basic personal and financial information, and to write a brief essay of 100 words or less to describe how the grant would help them have A Brighter Tomorrow.If you would like to apply for a Brighter Tomorrow grant, simply fill out our online application, print an application, or call 888-673-6287 to receive an application by mail. Applications are accepted from July 1 to October 1 of each year.For further information on the Brighter Tomorrow grant, call our Program Services Department at 1-888-MSFOCUS or you can contact us by email: support@msfocus.org.- Partially funded through a charitable donation from the Bayer Foundation.Official GuidelinesApplications submitted must fulfill the following eligibility criteria to be considered for funding: * Applicant must be diagnosed with MS, or be the parent of a minor child with MS. * Applicant must be over the age of 18. * Applicant must have no existing financial net (such as Medicaid or private insurance) to cover the request. * Applicant must grant the MSF the right to use their name and photograph for promotional purposes. * Applicant must agree to sign a disclaimer. * Applicant must be a resident of the United States. * Request must be for specific goods or services. * Cash, medications, or items available through current programs are not included.
Integra Foundation Neuroscience Nursing Foundation Research Grant Award
Award: $10,000Application Deadline: July 15, 2010. Applications must be received or postmarked by this date.
The purpose is to encourage qualified nurses to contribute to the advancement of neuroscience nursing through research. This research will be made available to the public and members of the health professions through publication and presentation at the AANN meetings.
Research fundingThe NNF Research Review Board will review applications and make recommendations to the NNF Board of Trustees on all proposals received.
Criteria for applicants•Principal investigator must be a registered nurse.•The project must be well defined and likely to contribute knowledge to neuroscience nursing.•Investigators are ready to start the research project, or are already in the process of conducting the research.
Neuroscience Nursing Foundation3007 Marx RoadRice, WA 99167Phone: 509.738.2542 Fax: 509.738.2580Email: nnf@nnfoundation.net
Certified Neuroscience Registered Nurse Recertification Grant Program
Through the Neuroscience Nursing Foundation CNRN Recertification Grant Program, NNF awards monies to Certified Neuroscience Registered Nurses (CNRNs) during their fifth year of certification (i.e., those who are up for recertification as a CNRN in the current year). Recertification grants are generously funded by the Integra Foundation and the American Board of Neuroscience Nursing. * Award Amount: $215 * Application Deadline: September 15, 2010
Friedreich's Ataxia Research Alliance New Investigator Grants
These grant awards are for young or new investigators who have demonstrated an interest in FA research and want to further that commitment. We believe in welcoming, mentoring and supporting new scientists in the FA research community so that they have the necessary experience and motivation to launch successful independent careers. Guidelines for New Investigator Grants New Investigator Grants are accepted twice a year March 1st and September 1st then awards are announced June 1st and December 1st. The terms of the awards are July 1 – June 30 for awards submitted March 1st and January 1 – December 31 for awards submitted September 1st. Grant proposals should not exceed 24 months in duration. Grant awards are made in one year allocations. All subsequent payments are contingent upon receipt and satisfactory review of a progress report. FARA reserves the right terminate any grant award for inadequate progress, failure to submit reports, deviation in scope of the original research, and/or changes in funding priority. All grants should be submitted using FARA’s Research Portfolio Management Program – www.curefa.org/rpmp On the Main Grant Page of the application please indicate “NIA” in the RFP field. A letter of support should be provided by the applicant’s supervisor/advisor. A personal statement from the applicant should also be included that addresses the applicant’s current interests, career goals and interest in Friedreich’s ataxia research. FARA only funds direct costs. No indirect costs will be awarded. A detailed budget must be submitted with all proposals, including a justification to support reported expenses. Reasonable and customary salary support and benefits are acceptable for the applicant. The budget should not exceed $100,000. Additional allowable expenses include: laboratory reagents and supplies, equipment, animal expenses, patient expenses directly related to study and not reimbursable by third party insurers, patient travel Expenses not awarded: indirect costs/overhead, travel to meetings and conferences, membership to scientific societies Individuals who receive this award cannot reapply through this same mechanism. This award is intended to help the scientist achieve additional sources of funding and independence. If human subjects are used in the proposed study, the study must be approved by the Institutional Review Board (IRB). Full funding will not be provided until proof of IRB approval is demonstrated to FARA. Human subjects studied in the course of research conducted under a grant are under no circumstances a responsibility of FARA. If animals are used in the proposed study, the study must be approved by the Institutional Animal Care and Use Committee (or equivalent) indicating that appropriate precautions have been taken to assure that proper treatment, care and humane conditions have been provided.
Friedreich's Ataxia Research Alliance 102 Pickering Way, Suite 200 Exton, PA 19341 USA Phone: (484) 875-3015 Fax: (610) 363-1506 Email: info@cureFA.org Website: www.cureFA.org
CUREPSP Society for Progressive Supranuclear Palsy Investigator-Initiated Research Projects
Grant submission deadline is April 1, 2010 Two, CBD-related grants are available for up to $75,000 for a period of one to two years
VISION Cure and prevent PSP and CBD
MISSION STATEMENT Increase awareness of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), fund research toward a cure and prevention, educate health professionals, and provide support, information and hope for persons and families with PSP and CBD.
The Society for Progressive Supranuclear Palsy (CurePSP) Research Program supports and promotes research that can advance the understanding and treatment of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
INVESTIGATOR-INITIATED RESEARCH CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular, cellular, and clinical levels.
CurePSP is particularly interested in research that will help us: 1. Understand the role of the tau gene and other genes in PSP and CBD. 2. Understand the role of tau protein processing in PSP and CBD. 3. Understand cellular energy metabolism and oxidative stress perturbations in PSP and CBD. 4. Understand environmental factors that influence the development or course of PSP and CBD. 5. Understand the series of changes brain cells pass through in PSP and CBD as they progress from healthy neurons to dysfunctional neurons. 6. Characterize the natural history of PSP and CBD in order to develop outcome measures for clinical trials. 7. Develop animal models of PSP and CBD. 8. Develop tools and disease markers for early diagnosis of PSP and CBD and for assessment of treatment. 9. Develop treatments that improve the symptoms of persons with PSP and CBD. 10. Develop interventions to arrest the progression of PSP and CBD and restore lost function.
CurePSP Executive Plaza III 11350 McCormick Road, Suite 906 Hunt Valley, MD 21031 Phone: 800-457-4777 E-mail: info@curepsp.org Website: www.curepsp.org
1234next
